Current:Home > MySimu Liu Reveals the Secret to the People’s Choice Awards—and Yes, It’s Ozempic -Excel Wealth Summit
Simu Liu Reveals the Secret to the People’s Choice Awards—and Yes, It’s Ozempic
View
Date:2025-04-18 16:19:13
Simu Liu is starting the night with a jab or two.
The 2024 People Choice Awards host couldn't help but poke fun at some of Hollywood's most popular cosmetic treatments during the Feb. 18 event.
"Welcome to the 49th annual People's Choice Awards," Simu explained launching into his opening monologue, "that's right, the show is almost 50 years old, but it is Hollywood."
"So, with a little Botox, some light filler and a couple months on Ozempic, it won't look a day over 31," the Barbie star continued. "I guarantee it."
And the actor is just the latest star to weigh in on the drug, originally intended to treat type 2 diabetes.
Most recently, Kelly Osbourne recently said that she thinks criticism of the drug comes from a place of jealousy.
"I think it's amazing," she told E! News while at Dolly Parton's Pet Gala red carpet Jan. 30."There are a million ways to lose weight, why not do it through something that isn't as boring as working out?"
Others, however, have been more hesitant about its weight loss benefits.
"I think it's very important we understand certain medications are made for certain people," Raven-Symoné told E! News in July, "and to not take that away just for glamazon purposes."
She continued, "Do what you gotta do, just make sure you save the medication for the people who actually need it."
But needless to say, Ozempic will continue to be a subject of debate for stars in Hollywood.
Keep reading to see which celebs made their way to the People's Choice Awards.
In Lena Berisha
In Roberto Cavalli
Watch the 2024 People’s Choice Awards tonight, Feb. 18, at 8 p.m. on NBC, E! and Peacock. E!'s Live From E! red carpet kicks off at 6 p.m. ET/3 p.m. PT.veryGood! (467)
Related
- Former Syrian official arrested in California who oversaw prison charged with torture
- Real Housewives of Potomac's Karen Huger Charged With DUI After Car Crash
- 12 NBA draft prospects to watch in men's NCAA Tournament
- Wisconsin GOP leader says Trump backers seeking to recall him don’t have enough signatures
- Stamford Road collision sends motorcyclist flying; driver arrested
- CVS CEO Karen Lynch on decision to carry the abortion pill, cybersecurity threats
- Members of WWII Ghost Army receive Congressional Gold Medals
- Federal Reserve March meeting: Rates hold steady; 3 cuts seen in '24 despite inflation
- $73.5M beach replenishment project starts in January at Jersey Shore
- Scott Boras addresses frustrating offseason of unsigned high-profile baseball players
Ranking
- Who's hosting 'Saturday Night Live' tonight? Musical guest, how to watch Dec. 14 episode
- This Real Housewives of Beverly Hills Star Is Leaving After Season 13
- I promised my kid I'd take her to see Bruce Springsteen. Why it took 12 years to get there
- Grid-Enhancing ‘Magic Balls’ to Get a Major Test in Minnesota
- Tarte Shape Tape Concealer Sells Once Every 4 Seconds: Get 50% Off Before It's Gone
- NC State riding big man DJ Burns on its unlikely NCAA Tournament run this March Madness
- Stock Up on Spring Cleaning Essentials in Amazon's Big Spring Sale: Air Purifiers for 80% Off & More
- Dodgers fire Shohei Ohtani's interpreter after allegations of theft to pay off gambling debts
Recommendation
McKinsey to pay $650 million after advising opioid maker on how to 'turbocharge' sales
You Only Have One Day To Shop These Insane Walmart Deals Before They're Gone
Mom of Utah grief author accused of poisoning her husband also possibly involved in his death, affidavit says
Beyoncé will receive the Innovator Award at the 2024 iHeartRadio Music Awards
The FTC says 'gamified' online job scams by WhatsApp and text on the rise. What to know.
Broadway star Sonya Balsara born to play Princess Jasmine in 'Aladdin' on its 10th anniversary
Colorado extends Boise State's March Madness misery. Can Buffs go on NCAA Tournament run?
Average long-term US mortgage rate climbs back to nearly 7% after two-week slide